Crickey Cavalier, It sounds like I've been listening to too many people bullish about CAS. Thanks for the different point of view.
Although I'm still bullish about Juruena and the upcoming scoping study .... I just have no idea how CAS will fund capex, if they want to get it to production, it seems Borborema is the obvious candidate if they need to sell an asset. I noticed that Morgans gave Borborema a price tag of $20M, I wonder if that's wishful thinking.
I also stated a few months ago when CAS was 17 cents, that without any further new news, the share price could down to ten cents if not lower, well it's now 12 cents, lol.
- Forums
- ASX - By Stock
- Dont understand this crowd
Crickey Cavalier, It sounds like I've been listening to too many...
Featured News
Add BRV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online